NCT00378573View on ClinicalTrials.gov

Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

docetaxel

DRUG

gemcitabine

DRUG

bevacizumab

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00378573 - Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter